(Q33750284)

29 July 2017

1 reference

title

The penetration of anti-infectives into the central nervous system (English)

1 reference

29 July 2017

Kearney BP

1

1 reference

29 July 2017

Aweeka FT

series ordinal

2

1 reference

29 July 2017

language of work or name

1 reference

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

17

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

883-900

1 reference

Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Tobramycin Levels in Cerebrospinal Fluid of Patients with Slightly and Severely Impaired Blood-Cerebrospinal Barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Netilmicin in human CSF after parenteral administration in patients with slightly and severely impaired blood CSF barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Amoxicillin Entry into Human Cerebrospinal Fluid: Comparison with Ampicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

High-Dose Ketoconazole for Treatment of Fungal Infections of the Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Expression of a multidrug-resistance gene in human tumors and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pyrazinamide and other drugs in tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

CSF pharmacokinetics of ceftazidime in neurosurgical patients with an external ventriculostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Comparative tissue and extravascular fluid concentrations of ceftizoxime

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

The entry of antiviral and antiretroviral drugs into the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Aminoglycoside Therapy of Gram-Negative Bacillary Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Vancomycin administration into the cerebrospinal fluid: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacokinetics of ceftriaxone in neonates and infants with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal fluid concentrations of ciprofloxacin in subjects with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Netilmicin cerebrospinal fluid concentrations after an intravenous infusion of 400 mg in patients without meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Ticarcillin for treatment of serious infections with gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal Fluid Penetration of Antimicrobials

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Bacterial meningitis. Practical guidelines for management

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Indinavir in cerebrospinal fluid of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

The P-glycoprotein efflux pump: how does it transport drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Advances in understanding the pharmacology of agents used to treat bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Study of the cerebrospinal fluid penetrability of ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Single-dose pharmacokinetics of aztreonam in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Cefotaxime therapy of bacterial meningitis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970171-7

7 January 2021

10.1016/S0733-8619(05)70171-7

Identifiers

DOI

1 reference

29 July 2017

1 reference